2025 Jeannie Ferris Award: Cancer Equity Champs Named

Cancer Australia

The Hon Mark Butler MP, Minister for Health and Ageing, Minister for Disability and the NDIS, has today named the recipients of the 2025 Jeannie Ferris Award, celebrating exceptional achievements by four individuals whose commitment has driven significant advances in equity for Australians affected by cancer.

Established in 2013, the Jeannie Ferris Award is a prestigious honour celebrating those who have made notable and enduring mark on cancer care, support and outcomes. The Award is presented in two categories: Members of the Community and Health Professionals and Researchers.

Members of the Community:

Mrs Lisa Briggs: A national voice for lung cancer awareness, Lisa Briggs turned her own battle with incurable, Stage IV lung cancer-diagnosed at just 32-into a catalyst for progress. Now more than a decade post-diagnosis, Lisa's advocacy champions dignity, equity, and visibility for metastatic lung cancer patients. Through key roles with groups like Thoracic Oncology Group Australasia, Lung Foundation Australia, Rare Cancers Australia, and ALK Positive Australia, she has driven patient-centred research and illuminated the challenges confronting those living with lung cancer, paving the way for crucial policy and systemic reforms.

Professor Margaret Heffernan OAM:

Margaret Heffernan OAM has made a significant contribution to the gynaecological cancer sector over the past 33 years. Her extensive work in a pro bono capacity as a survivor, consumer, advocate, educator and behavioural researcher has had sustained impact. It has helped reduce disparities and inequities and empowering health professionals, patients, carers, and survivors across all community sectors, particularly vulnerable populations. These efforts have also impacted hospital and treatment centre infrastructure, policy, social justice and equity. Margaret was recognised in a 2006 Order of Australia Medal, and subsequently nationally and internationally.

Health Professionals and Researchers:

Professor Gail Garvey AM, a proud Kamilaroi woman, was recognised for her internationally acclaimed leadership in Indigenous health research. With more than 30 years dedicated to improving cancer and wellbeing outcomes for Australia's First Nations peoples, Professor Garvey has developed culturally safe, patient-centred tools that have transformed cancer care, founded the World Indigenous Cancer Conference, and was appointed a Member of the Order of Australia and Fellow of the Queensland Academy of Arts and Sciences in 2024.

Associate Professor Mei Ling Yap, a radiation oncologist and clinician researcher, was honoured for over 15 years of advancing equitable cancer care in South-Western Sydney and beyond, with a focus on culturally and linguistically diverse and socio-economically disadvantaged communities. Her research has informed national and international cancer policy, including Australia's first national cancer plan, and she leads global initiatives to strengthen oncology systems across the Asia-Pacific.

Minister Butler presented the 2025 Jeannie Ferris Award to the recipients on 28 July at Australian Parliament House in Canberra, with Jeremy Ferris, son of the late Senator Jeannie Ferris, in attendance. Embodying Senator Ferris' enduring legacy, the Award continues to encourage progress towards equity of cancer outcomes for all Australians with all cancers, no matter where they live or who they are.

As stated by Minister Butler:

"I am delighted to announce the recipients of the 2025 Jeannie Ferris Award, which highlights the remarkable contributions of individuals dedicated to improving cancer awareness, research, and support across Australia."

"By celebrating individuals who have made significant strides in this area, we are reinforcing our commitment to ensuring that every Australian, regardless of background or location, has access to high-quality cancer care.

As stated by Professor Dorothy Keefe, CEO, Cancer Australia:

"The Jeannie Ferris Award supports and promotes the goals of the Australian Cancer Plan, which places equity at the heart of cancer care.

"This year's recipients exemplify the spirit of the Jeannie Ferris Award. Mrs Lisa Briggs, Professor Heffernan, Professor Garvey and Associate Professor Yap, have each made outstanding contributions to advancing equity in cancer care through their dedication and leadership."

As stated by Lisa Briggs

"Receiving the Jeanie Ferris award is a powerful reminder that every time we speak up, we keep someone else's dreams alive.

"It also honours 10 years of life, hope, and dreams I was never promised or guaranteed, but have dedicated to rewriting what's possible, to help build a brighter future for those living with lung cancer."

As stated by Professor Margaret Heffernan OAM

"I humbly accept the 2025 Jeannie Ferris Award on behalf of the invisible 'backroom' of heroes who have supported my vision for better outcomes, trekked with me unconditionally over the past 33 years. Jeannie's legacy is a reminder of the power of research, education, and advocacy in saving lives. We still have quite a journey ahead. Vale Jeannie, you were a tour de force!

As stated by Professor Gail Garvey AM

"Thank you, Cancer Australia, I am honoured to receive the 2025 Jeannie Ferris Award. This recognition inspires me to continue advancing to close the gap in cancer outcomes for Aboriginal and Torres Strait Islander peoples through culturally safe, community-driven care."

As stated by Associate Professor Mei Ling Yap

"The Jeannie Ferris Award reflects a shared vision to achieve equitable outcomes for every person affected by cancer, regardless of their identity, culture, socio-economic status or postcode. My work has been inspired by the people of South-Western Sydney Local Health District, who I have been privileged to provide clinical care to for over 15 years.

"This award also acknowledges the contribution of my research colleagues and the Australian cancer control community to improving outcomes globally. I have been very fortunate to have worked with dedicated colleagues from the Asia-Pacific Radiation Oncology Special Interest Group, RANZCR as well as global partners, to improve access to radiation therapy in our region."

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.